LETHAL AND NONLETHAL COURSE OF ENDOTOXIC-SHOCK IS DETERMINED BY INTERACTIONS BETWEEN TUMOR-NECROSIS-FACTOR, PLATELET-ACTIVATING-FACTOR AND EICOSANOIDS

被引:0
|
作者
MOZES, T
BENEFRAIM, S
BONTA, IL
机构
[1] ERASMUS UNIV,FAC MED,INST PHARMACOL,3000 DR ROTTERDAM,NETHERLANDS
[2] TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN MICROBIOL,TEL AVIV,ISRAEL
来源
PATHOLOGIE BIOLOGIE | 1992年 / 40卷 / 08期
关键词
ENDOTOXIC SHOCK; TNF-TUMOR NECROSIS FACTOR; PAF-PLATELET ACTIVATING FACTOR; EICOSANOIDS;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Continous lipopolysaccharide (LPS) infusion in pigs induced death in approximately half of the animals and a prolonged state of shock (up to 3 hours of experimental observation period, i.e., two hours after discontinuation of LPS infusion) in the surviving animals. Lethal-induced shock was marked by huge release of Tumor Necrosis Factor (TNF) into the blood, whereas eicosanoid and Platelet Activating Factor (PAF) levels remained unchanged. In pigs surviving LPS-infusion but still remaining in a state of shock, transient increases in PAF and thromboxane levels were observed, whereas prostacyclin and leukotrienes values remained above normal levels up to the end of the observation period. It's concluded that different types of mediators play a role in LPS-induced lethal shock as compared to non-lethal prolonged state of shock.
引用
收藏
页码:807 / 812
页数:6
相关论文
共 50 条
  • [41] INTRAPULMONARY TUMOR-NECROSIS-FACTOR TRIGGERS LOCAL PLATELET-ACTIVATING-FACTOR PRODUCTION IN RAT IMMUNE-COMPLEX ALVEOLITIS
    WARREN, JS
    BARTON, PA
    MANDEL, DM
    MATROSIC, K
    LABORATORY INVESTIGATION, 1990, 63 (06) : 746 - 754
  • [42] COOPERATION BETWEEN TUMOR-NECROSIS-FACTOR (TNF) AND PLATELET-ACTIVATING FACTOR (PAF) IN THE INFLAMMATORY RESPONSE
    MAESTRE, C
    ZARCO, P
    GOMEZGUERRERO, C
    GONZALEZ, E
    HERREROBEAUMONT, G
    BRAQUET, M
    EGIDO, J
    JOURNAL OF LIPID MEDIATORS, 1990, 2 : S151 - S159
  • [43] ROLE OF ENDOGENOUS TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1 AND PLATELET-ACTIVATING-FACTOR IN THE VASCULAR HYPOREACTIVITY IN RATS TREATED WITH ENDOTOXIN
    WU, CC
    SZABO, C
    THIEMERMANN, C
    VANE, JR
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 : P156 - P156
  • [44] DIFFERENTIAL EXPRESSION OF CYTOKINES AND TUMOR-NECROSIS-FACTOR RECEPTOR (TNFR) IN PLASMA OF NONHUMAN-PRIMATES SUBJECTED TO SUBLETHAL ENDOTOXIC-SHOCK
    KIRSCHNER, KF
    KITTELL, CL
    FARESE, AM
    WIDMER, M
    WILLIAMS, DE
    MACVITTIE, TJ
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 776 - 776
  • [45] Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock
    Zaitseva L.G.
    Vaisburd M.Yu.
    Shaposhnikova G.M.
    Mysyakin E.B.
    Bulletin of Experimental Biology and Medicine, 2000, 130 (9) : 879 - 881
  • [46] Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock
    Zaitseva, LG
    Vaisburd, MY
    Shaposhnikova, GM
    Mysyakin, EB
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 130 (09) : 879 - 881
  • [47] Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock
    L. G. Zaitseva
    M. Yu. Vaisburd
    G. M. Shaposhnikova
    E. B. Mysyakin
    Bulletin of Experimental Biology and Medicine, 2000, 130 (3) : 879 - 881
  • [48] RELATIONSHIP OF TUMOR-NECROSIS-FACTOR AND ENDOTOXIN TO MACROPHAGE CYTOTOXICITY, HEMORRHAGIC NECROSIS AND LETHAL SHOCK
    ROTHSTEIN, JL
    SCHREIBER, H
    CIBA FOUNDATION SYMPOSIA, 1987, 131 : 124 - 139
  • [49] MONOCLONAL-ANTIBODIES AGAINST HUMAN RECOMBINANT TUMOR NECROSIS FACTOR - PREVENTION OF ENDOTOXIC-SHOCK
    SHIMAMOTO, Y
    CHEN, RL
    BOLLON, A
    CHANG, A
    KHAN, A
    IMMUNOLOGY LETTERS, 1988, 17 (04) : 311 - 317
  • [50] TUMOR-NECROSIS-FACTOR INDUCES ENHANCED RESPONSES TO PLATELET-ACTIVATING-FACTOR AND DIFFERENTIATION IN HUMAN MONOCYTIC MONO MAC-6 CELLS
    WEBER, C
    AEPFELBACHER, M
    HAAG, H
    ZIEGLERHEITBROCK, HWL
    WEBER, PC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (04) : 852 - 859